Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

Expanding Our Understanding of Dystonia in Cerebral Palsy: Learning from Caregiver Experts

Author:Gilbert, Laura   Lott, Emma   Kim, Susie   Rust, Alyssa   McQueen, Amy   Aravamuthan, Bhooma   

Session Name:P11: Child Neurology and Developmental Neurology: Movement Disorders  

Topic:Child Neurology and Developmental Neurology  

Program Number:P11.007  

Author Institution:Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL  Washington University in St. Louis, St. Louis, MO  

Efficacy and Adverse Effects of Induced Hypertension for Vasospasm in Subarachnoid Hemorrhage: A Systematic Review

Author:Seneviratne, Namal   Lan, Zheng   Migdady, Ibrahim   

Session Name:P11: Neurocritical Care: Subarachnoid Hemorrhage  

Topic:Neurocritical Care  

Program Number:P11.008  

Author Institution:Montefiore Medical Center, Bronx, NY  University of Texas Health Houston, Houston, TX  

Listeria Brain Abscess Resembling Acute Stroke: A Case Report

Author:Shi, Swanny   Gupta, Rishi   

Session Name:P11: Infectious Disease: Challenging Neurological Manifestations of Bacterial Infections 2  

Topic:Infectious Disease  

Program Number:P11.008  

Author Institution:Montefiore Medical Center, Bronx, NY  

Sex-specific Cognitive Differences in ALS

Author:Grassano, Maurizio   Palumbo, Francesca   Iazzolino, Barbara   Moglia, Cristina   Calvo, Andrea   Chio, Adriano   

Session Name:P11: Neuromuscular and Clinical Neurophysiology (EMG): ALS 2  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P11.008  

Author Institution:Dept. of Neuroscience, University of Turin, Torino, Italy  

A Phase 4, Open-label Study Evaluating the Safety and Tolerability of Once Daily Rimegepant for Episodic Migraine Prevention

Author:Antinew, Jeremias   Fountaine, Robert   Loprinzo, Vittorio   Straghan, Esther   Fullerton, Terence   

Session Name:P11: Emerging Science  

Topic:Headache  

Program Number:P11.008  

Author Institution:Pfizer Inc, Groton, CT  Pfizer Inc, New York, NY  Pfizer Ltd., Surrey, United Kingdom